Abstract
Boron Neutron Capture Therapy (BNCT) is considered a promising therapy for the treatment of malignant brain tumors and malignant melanomas. Two boron compounds, the mercaptoundecahydro-closo-dodecaborate dianion ([B12H11,SH]2-, BSH) and boronophenylalanine (4-(dihydroxyboryl)phenylalanine, BPA), have entered the clinical research stage. (In both cases intracellular uptake by the target cells has been discussed.) For the evaluation of their pharmacokinetics and organ distribution, rather involved experimental techniques far from routine diagnostics are currently being used in treatment planning1, e.g. 18F-substitution in combination with PET or 11B MRI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
see this volume, e.g. contributions by: Y. Mishima; Y. Nakagawa & H. Hatanaka; H. Fukuda; K.M. Bradshaw et al.
G. Wolf, K.R. Burnett, E.J. Goldstein, and P.M. Joseph, Contrast agents for magnetic resonance imaging, in “Magnetic Resonance Annual’’, H.Y. Kressel, ed., Raven Press, New York, 1985, pp. 231–266.
R.F. Martin, G. D’Cunha, M. Pardee, B.J. Allen, Induction of double-strand breaks following neutron capture by DNA-bound15JGd. Int. J. Radiat. Biol. 54: 205–208, 1988.
R.M. Brugger, J.A. Shih, Evaluation of Gadolinium-157 as a neutron therapy agent. Strahlenther Onkol. 165: 153–156, 1989.
Y. S. Ryabukhin, Integrated approach in the planning of neutron capture therapy. Strahlenther Onkol. 165: 158–162, 1989.
J.A. Shih, R.M. Brugger, Gadolinium as a neutron capture therapy agent. Med. Phys. 19: 733–744, 1992.
J.T. Masiakowski, J.L. Horton, and L.J. Peters, Gadolinium neutron capture therapy for brain tumors: a computer study. Med. Phys. 19: 1–8, 1992.
T. Matsumoto, Transport calculations of depth-dose distributions for gadolinium neutron capture therapy. Phys. Med. Biol. 37: 155–162, 1992
Y. Akine, N. Tokita, T. Matsumoto, H. Oyama, S. Egawa, O. Aizawa, Radiation effect of gadolinium-neutron capture reactions on the survival of chinese hamster cells. Strahlenther. Onkol. 166: 831–833 1990.
M. Takagaki, Y. Oda, S. Miyatake, H. Kikuchi, T. Kobayashi, K. Kanda, Y. Ujeno, Killing effects of gadolinium neutron capture reactions on brain tumors, in “Progress in Neutron Capture Therapy tor Cancer’; B.J. Allen et al., eds. Plenum Press, New York, 1992, pp. 407–410.
Y. Akine, N. Tokita, T. Matsumoto, H. Oyama, O. Aizawa, Gadolinium-neutron capture reactions: a radiobiological assay, in “Progress in Neutron Capture Therapy for Cancer”. B.J. Allen et al., eds., Plenum Press, New York, 1992, pp. 361–363.
Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, T. Kobayashi, K. Kanda, Electron-equivalent dose for the effect of Gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice. Jpn. J. Clin. Oncol. 23: N3, 145–148, 1993.
Y. Akine, N. Tokita, K. Tokuuye, M. Satoh, H. Churei, C. LePechoux, T. Kobayashi, and K. Kanda, Suppression of rabbit VX-2 subcutaneous tumor growth by Gadolinium Neutron Capture Therapy. Jpn. J. Cancer Res. 84: 841–843, 1993.
C. Sundström and K. Nilsson, Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17: 565–577, 1976.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lawaczeck, R., Fischer, CO., Krüger, U., Leuther, W., Menrad, J. (1996). Gadolinium Neutron Capture Therapy (GdNCT) with MRI Contrast Media. In Vitro Studies. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_122
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_122
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive